A feasibility study quantifying in vivo human α-tocopherol metabolism

American Journal of Clinical Nutrition

Volumn 84, Issue 6, 2006, Pages 1430-1441

  Clifford, Andrew J ^a   De Moura, Fabiana F ^a   Ho, Charlene C ^a   Chuang, Jennifer C ^a   Follett, Jennifer ^a   Fadel, James G ^a   Novotny, Janet A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Accelerator mass spectrometry; Human; Isomer; Metabolism; Radiocarbon; Tocopherol

Indexed keywords

ALPHA 2(2' CARBOXYETHYL) 6 HYDROXYCHROMAN; ALPHA TOCOPHEROL; TOCOPHEROL DERIVATIVE;

ADULT; ARTICLE; DRUG ABSORPTION; DRUG DEGRADATION; DRUG ELIMINATION; FEASIBILITY STUDY; FECES LEVEL; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LIVER LEVEL; MALE; NORMAL HUMAN; QUANTITATIVE ANALYSIS; URINE LEVEL; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

EID: 33845488327     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.6.1430     Document Type: Article

References (74)

1. Ferslew KE, Acuff RV, Daigneault EA, Woolley TW, Stanton PE Jr. Pharmacokinetics and bioavailability of the RRR and all racemic stereoisomers of alpha-tocopherol in humans after single oral administration. J Clin Pharmacol 1993;33:84-8.
2. Burton GW, Traber MG, Acuff RV, et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr 1998;67:669-84.
3. Cohn W. Evaluation of vitamin E potency. Am J Clin Nutr 1999;69:156-8.
4. Hoppe PP, Krennrich G. Bioavailability and potency of natural-source and all-racemic alpha-tocopherol in the human: a dispute. Eur J Nutr 2000;39:183-93.
5. Blatt DH, Pryor WA, Mata JE, Rodriguez-Proteau R. Re-evaluation of the relative potency of synthetic and natural alpha-tocopherol: experimental and clinical observations. J Nutr Biochem 2004;15:380-95.
6. Blomstrand R, Forsgren L. Labelled tocopherols in man. Intestinal absorption and thoracic-duct lymph transport of dl-alpha-tocopheryl-3,4-14C2 acetate dl-alpha-tocopheramine-3,4-14C2 dl-alpha-tocopherol-(5-methyl-3H) and N-(methyl-3H)-dl-gamma-tocopheramine. Int Z Vitaminforsch 1968;38:328-44.
7. Mac Mahon MT, Neale G. The absorption of alpha-tocopherol in control subjects and in patients with intestinal malabsorption. Clin Sci 1970;38:197-210.
8. Gianello R, Libinaki R, Azzi A, et al. Alpha-tocopheryl phosphate: a novel, natural form of vitamin E. Free Radic Biol Med 2005;39:970-6.
9. Burton GW, Ingold KU, Foster DO, et al. Comparison of free alpha-tocopherol and alpha-tocopheryl acetate as sources of vitamin E in rats and humans. Lipids 1988;23:834-40.
10. Cheeseman KH, Holley AE, Kelly FJ, Wasil M, Hughes L, Burton G. Biokinetics in humans of RRR-alpha-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E. Free Radic Biol Med 1995;19:591-8.
11. Ingold KU, Burton GW, Foster DO, Hughes L, Lindsay DA, Webb A. Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids 1987;22:163-72.
12. Burton GW, Ingold KU, Cheeseman KH, Slater TF. Application of deuterated alpha-tocopherols to the biokinetics and bioavailability of vitamin E. Free Radic Res Commun 1990;11:99-107.
13. Traber MG, Ramakrishnan R, Kayden HJ. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol. Proc Natl Acad Sci U S A 1994;91:10005-8.
14. Leonard SW, Good CK, Gugger ET, Traber MG. Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am J Clin Nutr 2004;79:86-92.
15. Bruno RS, Leonard SW, Park SI, Zhao Y, Traber MG. Human vitamin E requirements assessed with the use of apples fortified with deuterium-labeled alpha-tocopheryl acetate. Am J Clin Nutr 2006;83:299-304.
16. Burton GW, Ingold KU, Traber MG, Kayden H. Reply to W Cohn. Am J Clin Nutr 1999;69:157-58 (letter).
17. Acuff RV, Thedford SS, Hidiroglou NN, Papas AM, Odom TA Jr. Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: studies using deuterated compounds. Am J Clin Nutr 1994;60:397-402.
18. Sowell AL, Huff DL, Yeager PR, Caudill SP, Gunter EW. Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection. Clin Chem 1994;40:411-6.
19. Morinobu T, Yoshikawa S, Hamamura K, Tamai H. Measurement of vitamin E metabolites by high-performance liquid chromatography during high-dose administration of alpha-tocopherol. Eur J Clin Nutr 2003;57:410-4.
20. Vogel JS. Rapid production of graphite without contamination for biomedical AMS. Radiocarbon 1992;34:344-50.
21. Ognibene TJ, Bench G, Vogel JS, Peaslee GF, Murov S. A high-throughput method for the conversion of CO2 obtained from biochemical samples to graphite in septa-sealed vials for quantification of 14C via accelerator mass spectrometry. Anal Chem 2003;75:2192-6.
22. Pope SA, Clayton PT, Muller DP. A new method for the analysis of urinary vitamin E metabolites and the tentative identification of a novel group of compounds. Arch Biochem Biophys 2000;381:8-15.
23. Vogel JS, Turteltaub KW, Finkel R, Nelson DE. Accelerator mass spectrometry. Anal Chem 1995;67:353A-9A.
24. Bjorneboe A, Bjorneboe GE, Drevon CA. Absorption, transport and distribution of vitamin E. J Nutr 1990;120:233-42.
25. Parker RS, Swanson JE, You CS, Edwards AJ, Huang T. Bioavailability of carotenoids in human subjects. Proc Nutr Soc 1999;58:155-62.
26. Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 2001;155:269-81.
27. Kaempf-Rotzoll DE, Traber MG, Arai H. Vitamin E and transfer proteins. Curr Opin Lipidol 2003;14:249-54.
28. Porter TD. Supernatant protein factor and tocopherol-associated protein: an unexpected link between cholesterol synthesis and vitamin E. J Nutr Biochem 2003;14:3-6.
29. Mardones P, Rigotti A. Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease. J Nutr Biochem 2004;15:252-60.
30. Stocker A. Molecular mechanisms of vitamin e transport. Ann NY Acad Sci 2004;1031:44-59.
31. Toth PP, Davidson MH. Therapeutic interventions targeted at the augmentation of reverse cholesterol transport. Curr Opin Cardiol 2004;19:374-9.
32. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 2005;49:7-30.
33. Stefanovski D, Moate PJ, Boston RC. WinSAAM: a Windows-based compartmental modeling system. Metabolism 2003;52:1153-66.
34. Novotny JA, Greif P, Boston RC. WinSAAM: application and explanation of use. Adv Exp Med Biol 2003;537:343-51.
35. Stahl W, Graf P, Brigelius-Flohe R, Wechter W, Sies H. Quantification of the alpha- and gamma-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2′- carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2′-carboxyethyl)-6- hydroxychroman in human serum. Anal Biochem 1999;275:254-9.
36. Radosavac D, Graf P, Polidori MC, Sies H, Stahl W. Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2, 7, 8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman (gamma-CEHC) in human serum after a single dose of natural vitamin E. Eur J Nutr 2002;41:119-24.
37. Bruno RS, Leonard SW, Li J, Bray TM, Traber MG. Lower plasma alpha-carboxyethyl-hydroxychroman after deuterium-labeled alpha-tocopherol supplementation suggests decreased vitamin E metabolism in smokers. Am J Clin Nutr 2005;81:1052-9.
38. Yoshikawa S, Morinobu T, Hamamura K, Hirahara F, Iwamoto T, Tamai H. The effect of gamma-tocopherol administration on alpha-tocopherol levels and metabolism in humans. Eur J Clin Nutr 2005;59:900-5.
39. Snyder WS, Cook MJ, Karhausen LR, Nasset ES, Howells GP Tipton IH, eds. Report of the Task Group on Reference Man. A report prepared by a task group of Committee 2 of the International Commission on Radiological Protection. ICRP Publication 23. Oxford, United Kingdom: Pergamon Press, 1975.
40. Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000.
41. Berman M. A postulate to aid in model building. J Theor Biol 1963;4:229-36.
42. Schultz M, Leist M, Petrzika M, Gassmann B, Brigelius-Flohe R. Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2′- carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am J Clin Nutr 1995;62(suppl):1527S-34S.
43. Ferrel P. Deficiency states, pharmacological effects, and nutrient requirements. New York, NY: Marcel Dekker Inc, 1980.
44. Clifford AJ. The whole animal as an analytical tool. New York, NY: Marcel Dekker Inc, 1984.
45. Schuelke M, Elsner A, Finckh B, Kohlschutter A, Hubner C, Brigelius-Flohe R. Urinary alpha-tocopherol metabolites in alpha-tocopherol transfer protein-deficient patients. J Lipid Res 2000;41:1543-51.
46. Horwitt MK. Vitamin E and lipid metabolism in man. Am J Clin Nutr 1960;8:451-61.
47. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995;15:325-33.
48. Kelleher J, Losowsky MS. The absorption of alpha-tocopherol in man. Br J Nutr 1970;24:1033-47.
49. Jeanes YM, Hall WL, Lodge JK. Comparative (2)H-labelled alpha-tocopherol biokinetics in plasma, lipoproteins, erythrocytes, platelets and lymphocytes in normolipidaemic males. Br J Nutr 2005;94:92-9.
50. Borel P, Pasquier B, Armand M, et al. Processing of vitamin A and E in the human gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2001;280:G95-103.
51. Hall WL, Jeanes YM, Lodge JK. Hyperlipidemic subjects have reduced uptake of newly absorbed vitamin E into their plasma lipoproteins, erythrocytes, platelets, and lymphocytes, as studied by deuterium-labeled alpha-tocopherol biokinetics. J Nutr 2005;135:58-63.
52. Massey JB. Kinetics of transfer of alpha-tocopherol between model and native plasma lipoproteins. Biochim Biophys Acta 1984;793:387-92.
53. Traber MG, Lane JC, Lagmay NR, Kayden HJ. Studies on the transfer of tocopherol between lipoproteins. Lipids 1992;27:657-63.
54. Kolleck I, Schlame M, Fechner H, Looman AC, Wissel H, Rustow B. HDL is the major source of vitamin E for type II pneumocytes. Free Radic Biol Med 1999;27:882-90.
55. Goti D, Hammer A, Galla HJ, Malle E, Sattler W. Uptake of lipoprotein-associated alpha-tocopherol by primary porcine brain capillary endothelial cells. J Neurochem 2000;74:1374-83.
56. Chicku S, Hamamura K, Nakamura T. Novel urinary metabolite of d-d-tocopherol in rats. J Lipid Res 1984;25:40-8.
57. Swanson JE, Ben RN, Burton GW, Parker RS. Urinary excretion of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J Lipid Res 1999;40:665-71.
58. Traber MG. The biological activity of vitamin E. Corvallis, OR: The Linus Pauling Institute, 1998.
59. Kiyose C, Muramatsu R, Kameyama Y, Ueda T, Igarashi O. Biodiscrimination of alpha-tocopherol stereoisomers in humans after oral administration. Am J Clin Nutr 1997;65:785-9.
60. Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 2002;277:25290-6.
61. Hosomi A, Arita M, Sato Y, et al. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997;409:105-8.
62. Morley S, Panagabko C, Stocker A, Atkinson J, Manor D. Structure-function relationship in the tocopherol transfer protein. Ann N Y Acad Sci 2004;1031:332-3.
63. Arita M, Nomura K, Arai H, Inoue K. alpha-tocopherol transfer protein stimulates the secretion of alpha-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc Natl Acad Sci U S A 1997;94:12437-41.
64. Horiguchi M, Arita M, Kaempf-Rotzoll DE, Tsujimoto M, Inoue K, Arai H. pH-dependent translocation of alpha-tocopherol transfer protein (alpha-TTP) between hepatic cytosol and late endosomes. Genes Cells 2003;8:789-800.
65. Qian J, Atkinson J, Manor D. Biochemical consequences of heritable mutations in the alpha-tocopherol transfer protein. Biochemistry 2006;45:8236-42.
66. Qian J, Morley S, Wilson K, Nava P, Atkinson J, Manor D. Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res 2005;46:2072-82.
67. Leonard SW, Terasawa Y, Farese RV Jr, Traber MG. Incorporation of deuterated RRR- or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein-null mice. Am J Clin Nutr 2002;75:555-60.
68. Kayden HJ. Tocopherol content of adipose tissue from vitamin E-deficient humans. Ciba Found Symp 1983;101:70-91.
69. Parker RS. Carotenoid and tocopherol composition of human adipose tissue. Am J Clin Nutr 1988;47:33-6.
70. Traber MG, Burton GW, Ingold KU, Kayden HJ. RRR- and SRR-alpha- tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. J Lipid Res 1990;31:675-85.
71. Traber MG, Rudel LL, Burton GW, Hughes L, Ingold KU, Kayden HJ. Nascent VLDL from liver perfusions of cynomolgus monkeys are preferentially enriched in RRR- compared with SRR-alpha-tocopherol: studies using deuterated tocopherols. J Lipid Res 1990;31:687-94.
72. Traber MG, Sokol RJ, Burton GW, et al. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest 1990;85:397-407.
73. Catignani GL, Bieri JG. Rat liver alpha-tocopherol binding protein. Biochim Biophys Acta 1977;497:349-57.
74. Traber MG, Elsner A, Brigelius-Flohe R. Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates. FEBS Lett 1998;437:145-8.